Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck

Table 2 Clinicopathological characteristics of all SCCHN patients

Patient #	Tumor location	Stadium			Grading	Therapy
Patient #	Tumor location	T	N	M	Grading	Surgery	RTx dose (Gy)
1	Oral cavity	2	2 cd	0	2	+	0
2	Larynx	4	2b	0	3	+	64
3	Oral Cavity	1	0	0	2	+	60
4	Oro/Hypopharynx	4	2a	0	2	+	64
5	Oropharynx	3	2	0	2	-	70
6	Oropharynx	1	2b	0	3	+	64
7	Oral Cavity	1	2a	0	2	+	64
8	Oro/Hypopharynx	1	0	0	2	+	64
9	Oral Cavity	1	0	0	2	+	64
10	Oral Cavity	1	0	0	3	+	0
11	Oropharynx	2	2a	0	2	+	0
12	Larynx	2	2b	0	3	+	0
13	Oropharynx	4	0	0	2	+	64
14	Oropharynx	2	0	0	3	+	64
15	Larynx	3	0	0	3	+	64
16	Larynx	4	1	0	3	+	0
17	Oropharynx	2	2b	0	3	+	0
18	Oropharynx	2	1	0	2	+	64
19	Larynx	2	1	0	2	+	64
20	Sinus	2	0	0	3	+	60
21	Larynx	4	0	0	3	+	0